Original ArticleIs 25(OH)D Associated with Cognitive Impairment and Functional Improvement in Stroke? A Retrospective Clinical Study
Introduction
The hormone vitamin D is essential for calcium metabolism and bone homeostasis. It has also been reported that vitamin D plays an important role in immune modulation, cell proliferation and differentiation, and regulation of cell growth.1 Generally speaking, vitamin D is biologically inactive; to be activated, it must be hydroxylated to 25-hydroxyvitamin D [25(OH)D] in the liver and to 1,25(OH)D in the kidney, which has the highest affinity for vitamin D receptors (VDRs). Although 1α hydroxylation of vitamin D occurs in the kidney, it has been shown that this process might occur locally in different cells and organs as well.2 Thus, measuring 25(OH)D is the best method for estimating the entire vitamin D status.2, 3
Poor vitamin D status is a public health problem, and low levels of this vitamin have been associated with cardiovascular disease and reported as a predictive factor for stroke.1, 4 Experimental studies have shown that vitamin D can prevent neurons from excitotoxic injury5 and that VDRs are activated by cerebral ischemia in animal models and in human stroke patients.6
Although several studies have reported a relationship between low vitamin D levels and an increased risk of stroke, only a few studies have reported low vitamin D levels as a predictor of high mortality and poor functional outcomes in the early stages of stroke.7 In this study, we investigated whether functional outcomes after neurological rehabilitation and cognitive impairment in individuals with stroke correlated with their plasma 25(OH)D levels. We hypothesized that low 25(OH)D levels in stroke patients are associated with less functional gain after neurological rehabilitation and greater cognitive impairment.
Section snippets
Materials and Methods
This study included the medical records of stroke patients who underwent an inpatient rehabilitation program between 2012 and 2014 and whose blood 25(OH)D levels were determined. Stroke diagnoses were determined for all patients using magnetic resonance imaging or computed tomography records. Chemiluminescent microparticle immunoassay with automated instruments was used to estimate the 25(OH)D levels. Criteria for exclusion included no recorded 25(OH)D levels, occurrence of stroke more than
Demographic Characteristics and Education Levels of the Patients
The ages, genders, and disease histories of the patients in the ischemic and hemorrhagic subgroups were similar (P > .05) (Table 1). Eighty percent of the patients were ischemic (n = 96), and 20% were in the hemorrhagic group (n = 24). The education levels of the patients in the ischemic group were lower than those in the hemorrhagic group (P < .05). The demographic data and comorbidities of the patients are summarized in Table 1.
Stroke Clinical Findings and Functional Outcomes
There were no differences between the ischemic and hemorrhagic
Discussion
Low vitamin D status has been associated with an elevated risk for cardiovascular, autoimmune, and infectious diseases.9, 10, 11, 12, 13, 14 In recent reports, vitamin D deficiency has been identified as a risk factor for ischemic stroke and has been found to be associated with the comorbidities that are traditional risk factors for ischemic stroke.4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 Whereas several studies emphasizing 25(OH)D as a risk factor for ischemic stroke have been published, few
Conclusion
Vitamin D might play an important role in predicting rehabilitation outcome and cognition in stroke patients. The results of our study suggest that individuals with lower 25(OH)D levels have worse rehabilitation outcomes and poorer cognitive function than individuals with higher levels of 25(OH)D. More studies are needed to identify the role of vitamin D on functional outcome following the neurological rehabilitation process and on the cognitive functions of stroke patients. Investigating
References (30)
- et al.
Discovery of transcriptional programs in cerebral ischemia by in silico promoter analysis
Brain Res
(2009: 26) - et al.
Extraskeletal effects of vitamin D: facts, uncertainties, and controversies
Joint Bone Spine
(2011) - et al.
Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?
J Am Coll Cardiol
(2008) - et al.
1,25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brain
Neurosci Lett
(1996) - et al.
1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis
Brain Res Mol Brain Res
(1997) - et al.
1,25-Dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells
Brain Res Mol Brain Res
(1994) - et al.
Immunosenescence and brain aging: can rejuvenation of immunity reverse memory loss?
Trends Neurosci
(2009) - et al.
Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain
J Chem Neuroanat
(2005) - et al.
The association between vitamin D and cognition: a systematic review
Ageing Res Rev
(2013) - et al.
Vitamin D supplementation: a promising approach for the prevention and treatment of strokes
Curr Drug Targets
(2011)
Vitamin D and calcium deficits predispose for multiple chronic diseases
Eur J Clin Invest
Vitamin D deficiency
N Engl J Med
25-Hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis
Ann Neurol
Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats
Endocrinology
Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients
Eur J Neurol
Cited by (0)
The author(s) declare(s) that there are no conflict of interests regarding the publication of this paper.
The authors have no financial disclosures.